BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30850971)

  • 1. How Often Do We Fail to Classify the Treatment Response with [
    Mattoli MV; Calcagni ML; Taralli S; Indovina L; Spottiswoode BS; Giordano A
    Mol Imaging Biol; 2019 Dec; 21(6):1210-1219. PubMed ID: 30850971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor response evaluation in patients with malignant melanoma undergoing immune checkpoint inhibitor therapy and prognosis prediction using
    Kitajima K; Watabe T; Nakajo M; Ishibashi M; Daisaki H; Soeda F; Tanemura A; Kanekura T; Yamazaki N; Ito K
    Jpn J Radiol; 2022 Jan; 40(1):75-85. PubMed ID: 34287739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUV Harmonization Between Different Hybrid PET/CT Systems.
    Rubello D; Colletti PM
    Clin Nucl Med; 2018 Nov; 43(11):811-814. PubMed ID: 30199381
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ito K; Kitajima K; Toriihara A; Ishibashi M; Nakahara T; Daisaki H; Ohe Y; Honda R; Kijima T; Hasegawa S; Nakajo M
    Ann Nucl Med; 2021 Nov; 35(11):1253-1263. PubMed ID: 34370219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
    Houdu B; Lasnon C; Licaj I; Thomas G; Do P; Guizard AV; Desmonts C; Aide N
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):421-428. PubMed ID: 30218317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction.
    Lasnon C; Salomon T; Desmonts C; Dô P; Oulkhouir Y; Madelaine J; Aide N
    Ann Nucl Med; 2017 Feb; 31(2):125-134. PubMed ID: 27812791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-scanner Aβ-PET harmonization using barrel phantom spatial resolution matching.
    Ruwanpathirana GP; Williams RC; Masters CL; Rowe CC; Johnston LA; Davey CE
    Alzheimers Dement (Amst); 2024; 16(1):e12561. PubMed ID: 38476638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of scanner harmonization on PET-based treatment response assessment in metastatic melanoma.
    Weisman AJ; Bradshaw TJ; Namias M; Jeraj R
    Phys Med Biol; 2020 Dec; 65(22):225003. PubMed ID: 32906111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-Retest Reproducibility of
    Kurland BF; Peterson LM; Shields AT; Lee JH; Byrd DW; Novakova-Jiresova A; Muzi M; Specht JM; Mankoff DA; Linden HM; Kinahan PE
    J Nucl Med; 2019 May; 60(5):608-614. PubMed ID: 30361381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Tumor Burden Assessed by Dual Time Point [
    Garcia-Vicente AM; Pérez-Beteta J; Pérez-García VM; Molina D; Jiménez-Londoño GA; Soriano-Castrejón A; Martínez-González A
    Mol Imaging Biol; 2017 Aug; 19(4):636-644. PubMed ID: 27981471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are lesion features reproducible between
    Constantino CS; Oliveira FPM; Silva M; Oliveira C; Castanheira JC; Silva Â; Vaz SC; Vieira P; Costa DC
    Eur Radiol; 2021 May; 31(5):3071-3079. PubMed ID: 33125562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonization of standard uptake values across different positron emission tomography/computed tomography systems and different reconstruction algorithms: validation in oncology patients.
    Song Y; Meng X; Cao Z; Zhao W; Zhang Y; Guo R; Zhou X; Yang Z; Li N
    EJNMMI Phys; 2023 Mar; 10(1):19. PubMed ID: 36920590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does PET SUV Harmonization Affect PERCIST Response Classification?
    Quak E; Le Roux PY; Lasnon C; Robin P; Hofman MS; Bourhis D; Callahan J; Binns DS; Desmonts C; Salaun PY; Hicks RJ; Aide N
    J Nucl Med; 2016 Nov; 57(11):1699-1706. PubMed ID: 27283930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous positron emission tomography (PET) assessment of metabolism with ¹⁸F-fluoro-2-deoxy-d-glucose (FDG), proliferation with ¹⁸F-fluoro-thymidine (FLT), and hypoxia with ¹⁸fluoro-misonidazole (F-miso) before and during radiotherapy in patients with non-small-cell lung cancer (NSCLC): a pilot study.
    Vera P; Bohn P; Edet-Sanson A; Salles A; Hapdey S; Gardin I; Ménard JF; Modzelewski R; Thiberville L; Dubray B
    Radiother Oncol; 2011 Jan; 98(1):109-16. PubMed ID: 21056487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Hori M; Onishi H; Tsuboyama T; Nakamoto A; Ota T; Eguchi H; Wakasa K; Hatazawa J; Tomiyama N
    Eur J Radiol; 2017 Sep; 94():64-69. PubMed ID: 28712692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.